Multidrug resistance protein 1 (ABCC1) confers resistance to arsenic compounds in human myeloid leukemic HL-60 cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multidrug resistance protein 1 (ABCC1) confers resistance to arsenic compounds in human myeloid leukemic HL-60 cells
Authors
Keywords
Acute myelocytic leukemia, Arsenic, Arsenic trioxide, HL-60 cells, Dimethylarsinic acid, Dimethylmonothioarsinic acid, Dimethyldithioarsinic acid, Reactive oxygen species, Multidrug resistance-associated proteins
Journal
ARCHIVES OF TOXICOLOGY
Volume 87, Issue 6, Pages 1013-1023
Publisher
Springer Nature
Online
2012-10-08
DOI
10.1007/s00204-012-0956-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Analysis of arsenic metabolites in HepG2 and AS3MT-transfected cells
- (2011) Takayuki Watanabe et al. ARCHIVES OF TOXICOLOGY
- Revisiting the differentiation paradigm in acute promyelocytic leukemia
- (2011) J. Ablain et al. BLOOD
- Comparative Toxicity of Arsenic Metabolites in Human Bladder Cancer EJ-1 Cells
- (2011) Hua Naranmandura et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Monomethylarsenic Diglutathione Transport by the Human Multidrug Resistance Protein 1 (MRP1/ABCC1)
- (2011) M. W. Carew et al. DRUG METABOLISM AND DISPOSITION
- Multidrug Resistance Protein 4 (MRP4/ABCC4) Regulates cAMP Cellular Levels and Controls Human Leukemia Cell Proliferation and Differentiation
- (2011) Sabrina Copsel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Arsenite Interacts Selectively with Zinc Finger Proteins Containing C3H1 or C4 Motifs
- (2011) Xixi Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Arsenic–glutathione conjugate transport by the human multidrug resistance proteins (MRPs/ABCCs)
- (2011) Elaine M. Leslie JOURNAL OF INORGANIC BIOCHEMISTRY
- A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
- (2010) R. W. Ahn et al. CLINICAL CANCER RESEARCH
- Arsenic tolerance in Arabidopsis is mediated by two ABCC-type phytochelatin transporters
- (2010) W.-Y. Song et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Arsenic Trioxide Controls the Fate of the PML-RAR Oncoprotein by Directly Binding PML
- (2010) X. W. Zhang et al. SCIENCE
- Identification of Arsenic-Binding Proteins in Human Cells by Affinity Chromatography and Mass Spectrometry
- (2009) Huiming Yan et al. ANALYTICAL CHEMISTRY
- Disruption of the Arsenic (+3 Oxidation State) Methyltransferase Gene in the Mouse Alters the Phenotype for Methylation of Arsenic and Affects Distribution and Retention of Orally Administered Arsenate
- (2009) Zuzana Drobna et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Arsenic-Induced Carcinogenesis—Oxidative Stress as a Possible Mode of Action and Future Research Needs for More Biologically Based Risk Assessment
- (2009) Kirk T. Kitchin et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Trivalent methylated arsenical-induced phosphatidylserine exposure and apoptosis in platelets may lead to increased thrombus formation
- (2009) Ok-Nam Bae et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Differential cytotoxic effects of arsenic compounds in human acute promyelocytic leukemia cells
- (2009) Vichaya Charoensuk et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Speciation of arsenic trioxide metabolites in blood cells and plasma of a patient with acute promyelocytic leukemia
- (2008) Yuta Yoshino et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines
- (2008) Z Diaz et al. LEUKEMIA
- Effects of endogenous hydrogen peroxide and glutathione on the stability of arsenic metabolites in rat bile
- (2008) Yayoi Kobayashi et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started